Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/05/2009 | WO2009029770A1 Enhancement of transgene expression from viral-based vaccine vecors by expression of suppressors of the type i interferon response |
03/05/2009 | WO2009028663A1 Anti-claudin-3 antibody |
03/05/2009 | WO2009028662A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
03/05/2009 | WO2009028639A1 Anti-epha2 antibody |
03/05/2009 | WO2009028575A1 Activator for blood coagulation factor vii promoter and utilization of the same |
03/05/2009 | WO2009028531A1 Docrine polypeptide and method of purifying recombinant fused protein using the same |
03/05/2009 | WO2009028253A1 Peptide production method |
03/05/2009 | WO2009027752A2 Process for producing hepcidin |
03/05/2009 | WO2009027041A1 Glycosylation profile analysis |
03/05/2009 | WO2009026716A1 Method for cellulase production |
03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
03/05/2009 | WO2008156704A3 Antibody-mediated modulation of allergy |
03/05/2009 | WO2008153903A3 Heterologous and homologous cellulase expression system |
03/05/2009 | WO2008141795A3 Cell-free protein synthesis of deuterated proteins for structural and functional studies by nmr spectroscopy |
03/05/2009 | WO2005094355A3 Methods for altering protein production rates |
03/05/2009 | WO2005079300A9 Protein kinase inhibitors and methods for identifying same |
03/05/2009 | US20090064351 Transgenic bird producing erythropoietin and method of constructing the same |
03/05/2009 | US20090062510 Human Chemotactic Cytokine I Polypeptides |
03/05/2009 | US20090062188 Disease-Associated Protein |
03/05/2009 | US20090062181 Mineral Collagen Chelates And Methods Of Making And Using Same |
03/05/2009 | US20090062139 Phytases, nucleic acids encoding them and methods for making and using them |
03/05/2009 | US20090061511 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
03/05/2009 | US20090061485 Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited |
03/05/2009 | US20090061484 Enzymatic hydrolysis of lignocellulosic feedstocks using accessory enzymes |
03/05/2009 | US20090061483 Acid fungal proteases |
03/05/2009 | US20090061482 Nucleotide sequences of coryneform bacteria coded for proteins participating in l-serine metabolism and method for microbial production of l-serine |
03/05/2009 | US20090061481 Highly-efficient hyperthermophilic dna ligase |
03/05/2009 | US20090061480 Nucleotide sequence encoding a modulator of nf-kb |
03/05/2009 | US20090061458 Heterooligomeric Taste Receptor |
03/05/2009 | US20090061444 Phytochrome-based fluorophores |
03/05/2009 | US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria |
03/05/2009 | US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
03/05/2009 | US20090060935 Amebiasis vaccine |
03/05/2009 | US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
03/05/2009 | US20090060919 BINDING MEMBERS FOR IgE MOLECULES |
03/05/2009 | US20090060916 Ligands that bind IL-4 and/or IL-13 |
03/05/2009 | US20090060914 Deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
03/05/2009 | US20090060907 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
03/05/2009 | DE102007041735A1 Use of a multi-functional active substance mixture comprising a peptide fraction and an amino acid fraction, for producing a formulation for regulating the outer skin conditions of mammals including humans |
03/05/2009 | CA2698146A1 Anti-epha2 antibody |
03/05/2009 | CA2697976A1 A process for producing a peptide hormone |
03/05/2009 | CA2697480A1 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin |
03/05/2009 | CA2697091A1 Glycosylation profile analysis |
03/05/2009 | CA2685714A1 Inducible mutagenesis of target genes |
03/04/2009 | EP2031066A1 Mutant and gene encoding the same |
03/04/2009 | EP2030986A1 Polypeptide derivative of parathyroid hormone (PTH) |
03/04/2009 | EP2029764A2 In vitro protein expression process comprising c fusion molecules |
03/04/2009 | EP1899476A4 Production of cellulase |
03/04/2009 | EP1608748B1 Ligational encoding of small molecules |
03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
03/04/2009 | EP1246917B1 Human stra6 polypeptides |
03/04/2009 | EP1176210B1 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein |
03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
03/04/2009 | CN101379184A Novel oxidoreductases and uses thereof |
03/04/2009 | CN101376888A Method for producing secretion expression recombinant human fibroblast growth factor-21 |
03/04/2009 | CN100465285C An extracting method of carnosine |
03/04/2009 | CN100465284C Functional mixed short peptide of peanuts, and a preparation method thereof |
03/04/2009 | CN100464639C A composition with heart rate reducing property |
03/03/2009 | US7498424 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
03/03/2009 | US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
03/03/2009 | US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly |
03/03/2009 | US7498411 P49/STRAP is a novel protein involved in gene regulation and cell proliferation |
03/03/2009 | US7498314 Expression vectors and uses thereof |
03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
03/03/2009 | US7498305 Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity |
03/03/2009 | US7498165 Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins |
03/03/2009 | US7498159 Transgenic fungal strain for use as bioreactor in synthesis of glucoamylase; ethanol fermentation |
03/03/2009 | US7498158 Termamyl-like alpha-amylase for starch conversion, ethanol, laundry, dish, hard surface cleaning, textile desizing and/or sweetner production |
03/03/2009 | US7498155 Providing a bacterium such as Geobacteraceae expressing a conductive proteinaceous pilus; culturing in medium containing an electron acceptor such as iron III oxide; coupling to circuit; self-assembling; no need for metallization |
03/03/2009 | US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders |
03/03/2009 | US7498153 Chimeric immunogens |
03/03/2009 | US7498152 Interferon-alpha polypeptides and conjugates |
03/03/2009 | US7498151 Variant TLR4 nucleic acid and uses thereof |
03/03/2009 | US7498150 Materials and methods to increase peptide chain expression |
03/03/2009 | US7498149 Proteins having effects of controlling cell migration and cell death |
03/03/2009 | US7498148 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide) |
03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
03/03/2009 | US7498139 Using presence of procalcitonin or procalcitonin partial peptides to detect septicemia; determining proprotein concentrations in sample |
03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
03/03/2009 | US7498127 Drug screening for cytostatic agent intracellular signaling inhibitor such as antitumor agents, antirheumatic agents; cardiovascular disorders; producing within a cell a fragment of heparin binding-epidermal growth factor (HB-EGF); determination of nuclear export of PLZF protein |
03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
03/03/2009 | US7498029 Photoimmunotherapies for cancer using combination therapies |
03/03/2009 | US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
03/03/2009 | CA2276108C Novel peptide, novel dna, and novel antibody |
03/03/2009 | CA2238278C Antigenic protein originating in malassezia |
02/26/2009 | WO2009026456A2 Poxvirus methods and compositions |
02/26/2009 | WO2009026393A2 Amino acid substituted molecules |
02/26/2009 | WO2009026338A1 Intracellular reporters |
02/26/2009 | WO2009026177A1 Psma binding ligand-linker conjugates and methods for using |
02/26/2009 | WO2009026131A2 Vectors and methods for improved expression of eukaryotic proteins in bacteria |
02/26/2009 | WO2009025300A1 Peptide capable of binding to immunoglobulin |
02/26/2009 | WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same |
02/26/2009 | WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer |
02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
02/26/2009 | WO2008157379A3 Covalent diabodies and uses thereof |